elisa test (Fujirebio Inc)
96
Structured Review
Fujirebio Inc
elisa test
Elisa Test, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 96/100, based on 341 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elisa+test/INNOTEST+hTAU+Ag/pm41926864-56-24-29
Average 96 stars, based on 341 article reviews
Elisa Test, supplied by Fujirebio Inc, used in various techniques. Bioz Stars score: 96/100, based on 341 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elisa+test/INNOTEST+hTAU+Ag/pm41926864-56-24-29
Average 96 stars, based on 341 article reviews
elisa test - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. Article Snippet: Background: The course of frontotemporal dementia (FTD) is heterogeneous and no predictors of survival are currently available.. Cerebrospinal fluid (CSF) tau dosage has been demonstrated to be useful in predicting outcome over time in a number of neurological disorders.. Objective: To assess CSF tau levels in FTD and to evaluate their prognostic value. Article Title: Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Article Snippet: NFL was detected in CSF samples using commercial ELISA kit (Uman Diagnostics NF-light® assay, Umea, Sweden). .. The levels of NFL in CSF were measured by fitting data to a four-parameter standard curve using GraphPad Prism Software Package (San Diego, CA, USA).CSF levels of t-tau were quantified with standard procedures, using commercially available Article Title: Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. Article Snippet: Our objective was to evaluate the CSF phospho-Tau 181 /total-Tau (p/t-Tau) ratio to distinguish between the two main forms of frontotemporal lobar degeneration (FTLD): FTLD with TDP-43 (FTLD-TDP) and FTLD with Tau inclusions (FTLDTau).. CSF p/t-Tau ratio was examined in 79 FTLD patients with predictable neuropathology, i.e. Tau (affected by progressive supranuclear palsy or carriers of mutations within the MAPT gene) or TDP-43 (carriers of mutations within granulin , C9orf72 , TARDBP genes or affected by FTD with motor neuron disease).. FTLD patients were randomly grouped in a training cohort ( n 39) to assess the best CSF p/t-Tau cut-off score according to ROC analysis, and a validation cohort ( n 40) to evaluate accuracy values of the identifi ed marker. Article Title: Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis. Article Snippet: .. CSF NfL was analyzed using an in-house enzyme-linked immunosorbent assay (ELISA) method, (Gaetani et al., 2018) while T-Tau was measured using the commercially available Article Title: In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use Article Snippet: Hu et al. (2013) [ ] , First validation cohort ( n = 30): 10 subjects (FTLD-TDP n = 3) with normal p/t-Tau, 20 subjects (FTLD-TDP n = 16) with decreased p/t-Tau Second validation cohort ( n = 100): 61 subjects (FTLD-TDP n = 6) with normal p/t-Tau and 39 subjects (FTLD-TDP n = 27) with decreased p/t-Tau , CSF , Aβ42, t-Tau, and p-Tau181: commercially available kits (AlzBio3; Innogenetics, Ghent, Belgium) Levels of other candidate CSF FTLD-TDP biomarkers were measured by modifying commercially available immunoassays: Multiplex assay: Agouti-related peptides and adrenocorticotropic hormones (Millipore, Billerica, MA) Singleplex assays: Eotaxin-3 (Millipore), Fas (Affymetrix/Procarta, Santa Clara, CA), and IL-23 (R&D Systems, Minneapolis, MN). IL-17 measurements were tried in 5 commercially available kits (Millipore; Life Technologies, Grand Island, NY; Affymetrix/Procarta; R&D Systems; and Affymetrix/eBioscience, San Diego, CA) with no reliably detectable levels. IL-17 in the original biomarker panel was thus replaced by IL-23 , Commercial immunoassays , First validation cohort: FTLD-TDP cases have decreased levels of p-tau181 and IL-23, and increased Fas Second validation cohort: CSF p-tau181/total tau ratio < 0.37 distinguishes FTLD-TDP from FTLD-tau, AD, and healthy seniors with 82% sensitivity and 82% specificity Reduced CSF p-tau181/total tau ratio represents a reproducible, validated biomarker for FTLD-TDP with performance approaching well-established CSF AD biomarkers. .. Borroni et al. (2015) [ ] , FTLD ( n = 79) , CSF , Article Title: Cerebrospinal Fluid Tau in Frontotemporal Lobar Degeneration: Clinical, Neuroimaging, and Prognostic Correlates Article Snippet: .. CSF concentrations were measured in duplicate by Article Title: The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use. Article Snippet: .. CSF NfL was analyzed using an in-house enzyme-linked immunosorbent assay (ELISA) method (Gaetani et al., 2018), while T-Tau was measured using the commercially available Article Title: Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease Article Snippet: .. CSF concentrations were measured in duplicate by an Enzyme-linked Immunosorbent Assay:Article Title: Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. Article Snippet: Background: The course of frontotemporal dementia (FTD) is heterogeneous and no predictors of survival are currently available.. Cerebrospinal fluid (CSF) tau dosage has been demonstrated to be useful in predicting outcome over time in a number of neurological disorders.. Objective: To assess CSF tau levels in FTD and to evaluate their prognostic value. Article Title: Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Article Snippet: NFL was detected in CSF samples using commercial ELISA kit (Uman Diagnostics NF-light® assay, Umea, Sweden). .. The levels of NFL in CSF were measured by fitting data to a four-parameter standard curve using GraphPad Prism Software Package (San Diego, CA, USA).CSF levels of t-tau were quantified with standard procedures, using commercially available Article Title: Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. Article Snippet: Our objective was to evaluate the CSF phospho-Tau 181 /total-Tau (p/t-Tau) ratio to distinguish between the two main forms of frontotemporal lobar degeneration (FTLD): FTLD with TDP-43 (FTLD-TDP) and FTLD with Tau inclusions (FTLDTau).. CSF p/t-Tau ratio was examined in 79 FTLD patients with predictable neuropathology, i.e. Tau (affected by progressive supranuclear palsy or carriers of mutations within the MAPT gene) or TDP-43 (carriers of mutations within granulin , C9orf72 , TARDBP genes or affected by FTD with motor neuron disease).. FTLD patients were randomly grouped in a training cohort ( n 39) to assess the best CSF p/t-Tau cut-off score according to ROC analysis, and a validation cohort ( n 40) to evaluate accuracy values of the identifi ed marker. Article Title: Calprotectin reveals distinct innate immune signatures in NMOSD, MOGAD, and multiple sclerosis. Article Snippet: .. CSF NfL was analyzed using an in-house enzyme-linked immunosorbent assay (ELISA) method, (Gaetani et al., 2018) while T-Tau was measured using the commercially available Article Title: In vivo diagnosis of TDP-43 proteinopathies: in search of biomarkers of clinical use Article Snippet: Hu et al. (2013) [ ] , First validation cohort ( n = 30): 10 subjects (FTLD-TDP n = 3) with normal p/t-Tau, 20 subjects (FTLD-TDP n = 16) with decreased p/t-Tau Second validation cohort ( n = 100): 61 subjects (FTLD-TDP n = 6) with normal p/t-Tau and 39 subjects (FTLD-TDP n = 27) with decreased p/t-Tau , CSF , Aβ42, t-Tau, and p-Tau181: commercially available kits (AlzBio3; Innogenetics, Ghent, Belgium) Levels of other candidate CSF FTLD-TDP biomarkers were measured by modifying commercially available immunoassays: Multiplex assay: Agouti-related peptides and adrenocorticotropic hormones (Millipore, Billerica, MA) Singleplex assays: Eotaxin-3 (Millipore), Fas (Affymetrix/Procarta, Santa Clara, CA), and IL-23 (R&D Systems, Minneapolis, MN). IL-17 measurements were tried in 5 commercially available kits (Millipore; Life Technologies, Grand Island, NY; Affymetrix/Procarta; R&D Systems; and Affymetrix/eBioscience, San Diego, CA) with no reliably detectable levels. IL-17 in the original biomarker panel was thus replaced by IL-23 , Commercial immunoassays , First validation cohort: FTLD-TDP cases have decreased levels of p-tau181 and IL-23, and increased Fas Second validation cohort: CSF p-tau181/total tau ratio < 0.37 distinguishes FTLD-TDP from FTLD-tau, AD, and healthy seniors with 82% sensitivity and 82% specificity Reduced CSF p-tau181/total tau ratio represents a reproducible, validated biomarker for FTLD-TDP with performance approaching well-established CSF AD biomarkers. .. Borroni et al. (2015) [ ] , FTLD ( n = 79) , CSF , Article Title: Cerebrospinal Fluid Tau in Frontotemporal Lobar Degeneration: Clinical, Neuroimaging, and Prognostic Correlates Article Snippet: .. CSF concentrations were measured in duplicate by Article Title: The value of CSF diagnostic and prognostic biomarkers in NMOSD and MOGAD in real-life use. Article Snippet: .. CSF NfL was analyzed using an in-house enzyme-linked immunosorbent assay (ELISA) method (Gaetani et al., 2018), while T-Tau was measured using the commercially available Article Title: Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease Article Snippet: .. CSF concentrations were measured in duplicate by an Software:Article Title: Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression Article Snippet: NFL was detected in CSF samples using commercial ELISA kit (Uman Diagnostics NF-light® assay, Umea, Sweden). .. The levels of NFL in CSF were measured by fitting data to a four-parameter standard curve using GraphPad Prism Software Package (San Diego, CA, USA).CSF levels of t-tau were quantified with standard procedures, using commercially available |